Skip to main content
Caplight Logo









Viomerse

Viomerse

Private
Pittsford, New YorkHealthcare & Life Scienceshttps://viomerse.com/

Last Round

Grant

Aug 15, 2021

Total Funding Raised

$730,395

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Viomerse is a healthtech company that develops high-fidelity surgical training phantoms and an extended reality remote training platform to provide immersive, risk-free surgical education.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, AR/VR Experiences, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

surgical trainingsurgical phantommedical simulationaugmented realityARextended realityXRremote proctoringsurgical educationtissue-mimicking materialmedtechsurgical guidancemedical device trainingperformance assessmentsurgical tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Viomerse Comparables

Compare Viomerse with similar companies based on industry and business-model similarity.

Viomerse comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inovus Medical
86%
SurgeonsLab AG
85%
VirtaMed
81%

Viomerse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 15, 2021
AcceleratorNov 7, 2019
GrantJun 18, 2019

Key People

Founding team and executive leadership

Michael Wilson, PhD

Chief Executive Officer

Executive Team

Steven Griffith

Chief Technology Officer

Executive Team

Viomerse Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 43% MoM.

  • May 15, 2026

    Monthly visitors grew 310% MoM, reaching 1K.

Viomerse Filings

Explore SEC and related filing metadata, where available.

Viomerse filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Viomerse's valuation, stock price, and market status.

Is Viomerse a public or private company?

Viomerse is a private company.

What is the current stock price of Viomerse?

Viomerse is a private company with no public stock price. Caplight tracks Viomerse's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Viomerse worth (valuation)?

Valuation information for Viomerse is not publicly available.

Can I buy Viomerse stock?

Viomerse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Viomerse's last funding round?

Viomerse's most recent funding round was Grant on August 15, 2021.

Who are the main investors in Viomerse?

Key investors in Viomerse include Luminate Accelerator, National Institutes of Health (NIH), National Science Foundation.

Will Viomerse IPO soon?

No public IPO plans have been announced for Viomerse.

How can I track Viomerse secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Viomerse's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsford, New York
Employee Range13
Year Founded2016
Last FundingAug 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?